Rotem Falach, a PhD candidate in Professor Yuval Nir’s Lab at Tel Aviv University, will showcase how open-source analytics and HD EEG are advancing understanding of sleep-dependent memory consolidation and Alzheimer’s-related neurophysiology.

Register Here»

Neurosom sits at the intersection of brain health and digital therapeutics. With the Sleep WISP™, and our FDA-approved AI software, we can deliver clinical therapies for patients and, over time, wellness solutions for proactive brain care, making restorative sleep accessible at scale.

Every three seconds, someone in the world develops dementia. Current solutions fall short: medications sedate without restoring brain health, while consumer wearables only track sleep but don’t improve it.
Our Sleep WISP™ system is a simple, wearable headband that can be safely self-administered at home — but it does much more than track sleep. It monitors brain activity in real time using EEG.

As we approach the Bend Venture Conference on October 16 and 17, Neurosom™ is gearing up to share our mission to optimize sleep and reduce the risk of dementia. Our company was founded by neuroscientists who pioneered innovations in brain monitoring. Through studying the brain, scientists learned that deep sleep is essential for clearing toxic proteins from the brain through the glymphatic system, the brain’s waste removal pathway. When deep sleep is disrupted, glymphatic clearance fails, memory suffers, and neurodegeneration accelerates. 

A new study published in Neurology, following 2750 cognitively healthy adults over six years, found that participants with chronic insomnia were 40% more likely to develop cognitive impairment or dementia compared to those without the sleep disorder.

Neurosom™ is extremely honored to have been chosen as a Development Stage Finalist for the Oregon Entrepreneur Network Awards. We are proud to share our vision for better brain health and to be recognized among the best and brightest in Oregon's entrepreneurial community.

Last night at the "On the Road to BVC" event at Worthy Brewery in Bend, Viral joined other company founders to deliver a 3 minute pitch to judges and a live audience. When the votes were counted, we were grateful to be chosen among so many other great Oregon entrepreneurs. We look forward to having the opportunity to share our vision for Sleep Therapy and reducing dementia risk at the Bend Venture Conference, which happens October 16-17 in beautiful downtown Bend.

Join us for the PubTalk event this Thursday, September, 25th at Worthy Brewing in Bend, OR, on the road to BVC, where our CEO Viral Sheth will join other competitors in delivering a three-minute pitch to a live audience. The audience, along with a panel of judges, will decide who gets to present at the Tower Theater during the Bend Venture Conference October 16-17, 2025.

New informative article: "Better Sleep Could Help Your Brain Flush Out Dementia-Linked Toxins". This well-written description of glymphatic clearance recently published in Science Direct gives readers a deep dive into how improving sleep can reduce the risk for Dementia.

The lengthy study by authors Lutz, Harkotte, and Born states, in the abstract, "A promising new area arising from this research pertains to brain-stimulation techniques developed to enhance memory consolidation during human sleep."

Thanks to Launch Oregon for a fantastic event last week. Our CEO Viral Sheth and our founder and chairman Don Tucker shared their vision for Sleep Therapy and reducing dementia risk with this group supporting business through innovative research.

A terrific article in last month’s Scientific American highlights the connection between poor-quality sleep and a heightened risk of dementia.

Here, Dr. Rhonda Patrick explains the link between poor sleep and an increased risk for dementia, and what the phrase glymphatic clearance means.

Scientists studied EEG patterns in elderly subjects and, with the assistance of AI, found a correlation between irregular EEG activity and mild cognitive impairment. The future utility of EEG in the detection of neurodegenerative illness opens an area of keen interest, as current diagnostic methods often do not detect MCI until it has progressed to dementia. Read the article: https://lnkd.in/eNuMyiwj

BEL Webinar: Investigating the Role of Sleep In Parkinson's Disease Using the Sleep WISP™. August 29th, 10am PT, 1pm ET.

✅March 5-6: Requested to pitch at the MedTech Innovator West Coast event in Los Angeles
✅March 17th-21st: Invited to present at LSI in Dana Point
✅April 4th: Chosen by the Oregon Entrepreneurs Network to speak at the Angel Oregon Technology Pitch Practice Event
✅April 18th: Selected to showcase at LSI Asia in Singapore

✅May 1st: Recognized as a 2025 Oregon Emerging Tech Award Finalist by the Technology Association of Oregon

✔ FDA clearance of NEAT sleep staging software
✔ Sleep WISP™ in use with KOLs at Institutions like Mount Sinai, Wake Forest University, Oregon Health and Science University, Northwestern University and the Sleep and Brain Clinic in Menlo Park
✔ FDA clearance for Sourcerer (source localization) software
✔ Phase II National Institute of Aging (NIA) funding for effectiveness of Sleep WISP therapy on Mild Cognitive Impairment (MCI)

We truly connected with so many experienced, dedicated people who shared our vision of changing the future of brain health care with the Sleep WISP™. Thank you!

NEAT uses artificial intelligence (AI) to classify sleep stages from the sleep EEG accurately. It can be used in two modes: online (near-real time) and offline. Neurosom™, the BEL partner company that provides personalized closed-loop neuromodulation therapy to lower the risk of dementia, uses NEAT as a core part of its technology.

Neurosom™ will be presenting at LSI USA ‘25, taking place March 17-21 at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, California. During the event, our CEO, Viral Sheth, will present our Sleep WISP™ device, a personalized neuromodulation therapy to reduce the risk of dementia.
Attending #LSIUSA25? Connect with Viral Sheth, to explore Medtech’s future and potential collaborations.